Published on September 27, 2017
Professor Joe O'Sullivan, prostate cancer specialist at Queen's University in Belfast, provides us with an update of the news from ESMO 2017 for prostate cancer patients. Professor O'Sullivan highlights the results of the STAMPEDE trial as the most interesting topic presented at ESMO.
This interview was recorded by Skype. Prostate cancer videos about ESMO 17 are part of an educational program by the Patient Empowerment Foundation (PEF). We thank Bayer for their support.